IGF2BP3 and colorectal carcinoma: Similarly, the overexpression of IGF2BP3 in CRC significantly correlates with poor outcomes, with its ability to stabilize mRNAs of key genes like CCND1 and VEGF enhancing cell cycle progression and angiogenesis [65].